Barriers to Acquiring Assistive Technology: Cost and Lack of Information

1992 ◽  
Vol 86 (9) ◽  
pp. 402-407 ◽  
Author(s):  
M.M. Uslan

This article discusses two major obstacles that visually impaired persons face when considering the purchase of assistive technology—cost and lack of information about technology and financial assistance programs. The results of a survey of direct service organizations and three telephone surveys of visually impaired persons are presented to document the problem. Implications for administrators who wish to develop a financial assistance program are discussed.

2017 ◽  
Vol 2 (1) ◽  
pp. 83-93
Author(s):  
Syarul Azman Shaharuddin ◽  
Zulkifli Abd Hamid ◽  
Fakhri Sungit

The knowledge about zakat distribution method is a vital issue because it leaves an impact to the converts regarding fairness and satisfaction. The aim of the study is to analyze the zakat distribution method in the state of Selangor. In addition, the study is to delve the statisctics in the form of assistance programs received by the converts in Selangor. The study employs mixed method which adopts both quantitative and qualitative studies. The quantitative study employs the questionnaire instrument to 454 converts in Selangor. Meanwhile, the qualitative study employs the library study. The finding of the study indicates that there are twelve zakat distribution methods. The study also shows the statistics in the form of assistance program received by converts.There are fifteen forms of aid received by converts. In the one hand, the highest form of assistance program received by converts are hari raya allowance and monthly financial assistance which are amounted to 54.4% and 47.6% respectively. On the other hand, the lowest form of assistance program is printing and publication assistance which is amounted to 7%. The implication signifies that the zakat distribution method is dessiminated either in the form of money as well as services. Thus, the study finds that the zakat authority in Selangor has fairly distributed the funds into 1/8 of the right of zakat recipients.


1993 ◽  
Vol 87 (4) ◽  
pp. 106-110 ◽  
Author(s):  
W.C. Mann ◽  
D. Hurren ◽  
J. Karuza ◽  
D.W. Bentley

This study examined the use and need for assistive devices by 30 noninstitutionalized older visually impaired persons during intensive interviews in the subjects’ homes. It found a high rate of use of these devices, as well as the subjects’ expressed need for additional devices that they did not own. In addition, some of the subjects’ suggestions for the development of new devices indicated that the subjects did not have the latest information on assistive technology.


2017 ◽  
Vol 13 (3) ◽  
pp. e240-e248 ◽  
Author(s):  
S. Yousuf Zafar ◽  
Jeffrey Peppercorn ◽  
Akwasi Asabere ◽  
Alex Bastian

Objective: Pharmaceutical manufacturers sponsor drug-specific patient assistance programs that provide eligible patients with financial assistance, either in the form of providing the drug free of charge or copayment assistance. Describing these programs and determining who receives assistance is an important first step in understanding the impact and role of financial assistance in cancer care. Our objective was to describe eligibility criteria and benefits for cancer-specific, manufacturer-sponsored patient assistance programs. Methods: We conducted a prospective review of patient assistance program Web sites and called patient assistance program telephone hotlines from the perspective of a patient or caregiver requesting program details. Results: We identified 24 manufacturers with patient assistance programs, covering 87% of Food and Drug Administration–approved oncology drugs. For free drug programs, the average maximum annual income for qualification was $86,279. For copayment assistance programs, the average was $104,790. Thirty-five percent of free drug programs and 53% of copayment assistance programs declined to provide details on how financial need was determined. None of the programs shared details on patient usage statistics. Conclusion: Variation exists in the quality and quantity of data available to patients seeking financial assistance for cancer treatment via manufacturer Web sites and hotlines. Greater transparency among patient assistance programs would enhance utility for patients and help to determine the net impact on costs and adherence.


2021 ◽  
Vol 21 (1) ◽  
pp. 3-10
Author(s):  
Ingmar BEŠIĆ ◽  
◽  
Zikrija AVDAGIĆ AVDAGIĆ ◽  
Kerim HODŽIĆ

Visual impairments often pose serious restrictions on a visually impaired person and there is a considerable number of persons, especially among aging population, which depend on assistive technology to sustain their quality of life. Development and testing of assistive technology for visually impaired requires gathering information and conducting studies on both healthy and visually impaired individuals in a controlled environment. We propose test setup for visually impaired persons by creating RFID based assistive environment – Visual Impairment Friendly RFID Room. The test setup can be used to evaluate RFID object localization and its use by visually impaired persons. To certain extent every impairment has individual characteristics as different individuals may better respond to different subsets of visual information. We use virtual reality prototype to both simulate visual impairment and map full visual information to the subset that visually impaired person can perceive. Time-domain color mapping real-time image processing is used to evaluate the virtual reality prototype targeting color vision deficiency.


1983 ◽  
Vol 14 (3) ◽  
pp. 13-19 ◽  
Author(s):  
Charles J. Vander Kolk

Legally blind clients present a unique challenge to the rehabilitation counselor in that visual impairment includes a host of conditions that may arise from disease, genetic factors, and accidents that affect a very important sense organ. Psychosocial and attitudinal aspects can be barriers or they can facilitate adjustment to the disability. Many devices and methods of service have enhanced the rehabilitation prospects of visually impaired persons. Technological advances, programs for independent living and vocational development, the expertise of the rehabilitation counselor, and many service organizations provide the potential to meet the needs of this clientele.


2015 ◽  
Vol 58 (1) ◽  
pp. 108-126 ◽  
Author(s):  
Antonio Goucha Soares

The article is intended to debate two questions regarding the involvement of the Commission in the Troika's action: firstly, considering the nature of financial assistance programs, it aims to discuss the effect of the Commission's participation in Troika negotiations on the balance of power of the EU institutions; and secondly, the article raises the issue of the Commission's liability for the results achieved by the financial assistance program, taking into account the extent of the conditions imposed, as well as the intensity of scrutiny by the Troika.


2020 ◽  
pp. 107815522097026
Author(s):  
Seyram S Fudzie ◽  
Brandon Luong ◽  
Stephanie J Jean ◽  
Suzanne J Francart

Introduction Medication prior authorizations (PA) required by insurance payers can be time-consuming to complete and may lead to delays in treatment for cancer patients. The primary objective of this study is to assess the impact of Medication Assistance Program (MAP) specialists embedded in adult hematology and oncology clinics on the PA and financial assistance process. Methods This was a retrospective chart review study performed at a large academic medical center that examined medication referrals completed by MAP specialists in four hematology and oncology clinics. The primary outcome was the median PA turnaround time, defined as time from initial referral creation to final referral completion. Secondary outcomes assessed median turnaround time for financial assistance programs and total patient savings. Results A total of 176 prior authorization, 92 manufacturer patient assistance program (PAP), and 37 copay assistance referrals were completed. The median turnaround times were 24, 154, and 19 hours for PA, manufacturer PAP, and copay assistance program referrals, respectively. Total cost savings amounted to over $1.8 million for patients approved to receive medications through manufacturer PAPs. Conclusions Embedding MAP specialists in adult hematology/oncology clinics supports an efficient and timely process for PA approvals while also providing patient cost-savings.


Sign in / Sign up

Export Citation Format

Share Document